Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANVS

Annovis Bio Inc

Apr 30 • 10:25AM ET

1.92

+0.08 4.35 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: BIIB ACAD AXSM FLNA NBIX AVXL NERV PRTA PRQR RNA

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.40	Insider Own	16.96%	Shs Outstand	34.53M	Perf Week	6.08%
Market Cap	66.30M	Forward P/E	-	EPS next Y	-1.31	Insider Trans	48.26%	Shs Float	28.68M	Perf Month	-13.90%
Enterprise Value	46.77M	PEG	-	EPS next Q	-0.40	Inst Own	15.14%	Short Float	16.60%	Perf Quarter	-31.67%
Income	-28.85M	P/S	-	EPS this Y	9.64%	Inst Trans	15.40%	Short Ratio	6.66	Perf Half Y	-8.57%
Sales	0.00M	P/B	3.10	EPS next Y	-3.56%	ROA	-164.85%	Short Interest	4.76M	Perf YTD	-44.51%
Book/sh	0.62	P/C	3.39	EPS next 5Y	-8.94%	ROE	-220.61%	52W High	5.50 -65.09%	Perf Year	28.86%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-171.23%	52W Low	1.36 41.70%	Perf 3Y	-86.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.32% 9.24%	Perf 5Y	-91.33%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.86%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.80	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.69	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.80	EPS Q/Q	17.04%	SMA20	1.37%	Beta	1.25	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-14.79%	Rel Volume	1.08	Prev Close	1.84
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 16 BMO	SMA200	-28.07%	Avg Volume	714.64K	Price	1.92
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.46% -	Trades		Volume	142,285	Change	4.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)